Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54,102,569
-
Total 13F shares
-
29,670,168
-
Share change
-
+16,702,360
-
Total reported value
-
$156,599,526
-
Put/Call ratio
-
365%
-
Price per share
-
$5.28
-
Number of holders
-
60
-
Value change
-
+$91,818,405
-
Number of buys
-
40
-
Number of sells
-
14
Institutional Holders of Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) as of Q4 2024
As of 31 Dec 2024,
Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,670,168 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., TORONTO DOMINION BANK, Opaleye Management Inc., Blackstone Inc., Velan Capital Investment Management LP, Sio Capital Management, LLC, Integral Health Asset Management, LLC, and VANGUARD GROUP INC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.